Related Experiment Video

Updated: Dec 27, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.4K

A role for connexin-43 in Duchenne muscular dystrophy cardiomyopathy

Robin M Shaw1, Jeffrey E Saffitz2

  • 1Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah, USA.

The Journal of Clinical Investigation
|February 25, 2020
PubMed

Insights

Duchenne muscular dystrophy (DMD) cardiomyopathy involves connexin-43 (Cx43) changes. Hypophosphorylation of Cx43 worsens heart problems, but targeting this may improve cardiac function in DMD patients.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) cardiomyopathy is a major cause of death in patients.
  • Altered expression and localization of connexin-43 (Cx43), a key gap junction protein, are implicated in DMD cardiomyopathy.
  • The C-terminus of Cx43 contains regulatory serine residues crucial for its function.

Purpose of the Study:

  • To investigate the role of Cx43 hypophosphorylation at serine residues (S325/S328/S330) in the C-terminus on DMD cardiomyopathy.
  • To determine if modulating Cx43 phosphorylation can ameliorate cardiac dysfunction in a mouse model.

Main Methods:

  • Utilized a mouse model of DMD cardiomyopathy with phosphomimetic glutamic acid substitutions for serine residues (S325/S328/S330) in Cx43.
  • Assessed gap junction remodeling, Cx43 localization, response to isoproterenol challenge, and intracellular calcium (Ca2+) handling.

Main Results:

  • The phosphomimetic Cx43 mutation reduced gap junction remodeling and Cx43 lateralization.
  • This modification provided protection against isoproterenol-induced arrhythmias.
  • Improved Ca2+ homeostasis was observed in the modified mouse model.

Conclusions:

  • Hypophosphorylation of Cx43 at S325/S328/S330 contributes significantly to DMD cardiomyopathy features.
  • Targeting Cx43 phosphorylation represents a potential therapeutic strategy for mitigating cardiac dysfunction and arrhythmias in DMD.
  • Further research is warranted to develop interventions for DMD cardiac complications.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.2K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.5K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
299
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
365
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
380
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
423
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
249